Home › Funds › ODDO BHF ASSET MANAGEMENT SAS › ASND

ODDO BHF ASSET MANAGEMENT SAS position in ASND

ASCENDIS PHARMA A/S · Health Care

ODDO BHF ASSET MANAGEMENT SAS reported holding 84,252 shares of ASND (ASCENDIS PHARMA A/S) in its Q3 2026 13F filing — a position valued at US$19.2M, representing 0.91% of its reported portfolio and ranking #35 among its reported holdings. ODDO BHF ASSET MANAGEMENT SAS has disclosed ASND holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)84.25K sh
Reported value held$19.20M
Portfolio Weight0.91%
First reportedQ2 2025
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How ODDO BHF ASSET MANAGEMENT SAS's ASND position evolved

ODDO BHF ASSET MANAGEMENT SAS first disclosed a stake in ASND in Q2 2025 at 63,547 shares (US$11.0M). The position peaked in Q2 2026 at 128,657 shares, worth US$34.3M. Across 6 filings, ODDO BHF ASSET MANAGEMENT SAS increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 84,252 shares valued at US$19.2M — a reduction of -44,405 shares quarter over quarter.. Notable position changes include a 89% increase in Q3 2025 (shares rose 7% over the following quarter), a 100% trim in Q4 2025 (shares rose 7% over the following quarter), a 79811% increase in Q2 2026 (shares fell 15% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 63.55K $10.97M New
Q3 2025 119.98K $23.85M Add
Q4 2025 161 $229.47K Reduce
Q1 2026 161 $236.99K Hold
Q2 2026 128.66K $34.32M Add
Q3 2026 84.25K $19.20M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ASND and 13F data

ASND (ASCENDIS PHARMA A/S) is a Health Care company. 36 other funds we track also report a position in ASND — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$2.74B), T. Rowe Price Investment Management, Inc. (US$1.80B), WESTFIELD CAPITAL MANAGEMENT CO LP (US$1.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ASND

All ASND fund holders →

FAQ

How long has ODDO BHF ASSET MANAGEMENT SAS held ASND?

ODDO BHF ASSET MANAGEMENT SAS has disclosed ASND holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is ODDO BHF ASSET MANAGEMENT SAS's current position in ASND?

As of Q3 2026, ODDO BHF ASSET MANAGEMENT SAS holds 84.25K shares of ASND (ASCENDIS PHARMA A/S), valued at $19.20M, representing 0.91% of its reported portfolio and ranking #35.

Has ODDO BHF ASSET MANAGEMENT SAS been buying or selling ASND?

In the latest 13F filing (Q3 2026), ODDO BHF ASSET MANAGEMENT SAS reduced its position in ASND. The position peaked in Q2 2026 at 128.66K shares.

Which other funds hold ASND?

Other major institutional holders of ASND include RA CAPITAL MANAGEMENT, L.P., T. Rowe Price Investment Management, Inc., WESTFIELD CAPITAL MANAGEMENT CO LP, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.